Artículos de revistas sobre el tema "EXtremely Drug Resistant Tuberculosis"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "EXtremely Drug Resistant Tuberculosis".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Polsfuss, Silke, Sabine Hofmann-Thiel, Matthias Merker, David Krieger, Stefan Niemann, Holger Rüssmann, Nicolas Schönfeld, Harald Hoffmann y Katharina Kranzer. "Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment". Clinical Infectious Diseases 69, n.º 7 (2 de febrero de 2019): 1229–31. http://dx.doi.org/10.1093/cid/ciz074.
Texto completoMigliori, G. B., R. Centis, L. D'Ambrosio, A. Spanevello, E. Borroni, D. M. Cirillo y G. Sotgiu. "Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?" Clinical Infectious Diseases 54, n.º 9 (9 de abril de 2012): 1379–80. http://dx.doi.org/10.1093/cid/cis128.
Texto completoAntonenko, Kate, Valentin Kresyun y Peter Antonenko. "Mutations leading to drug-resistant Mycobacterium tuberculosis infection in Ukraine". Open Medicine 5, n.º 1 (1 de febrero de 2010): 30–35. http://dx.doi.org/10.2478/s11536-009-0114-6.
Texto completoAllué-Guardia, Anna, Rajagopalan Saranathan, John Chan y Jordi B. Torrelles. "Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis". International Journal of Molecular Sciences 22, n.º 2 (13 de enero de 2021): 735. http://dx.doi.org/10.3390/ijms22020735.
Texto completoMumena, David Kajoba, Geoffrey Kwenda, Caroline Wangari Ngugi y Andrew Kimanga Nyerere. "Drug-Resistant Tuberculosis Types and Their Treatment Regimens Using First-Line, Second-Line Injectable, Third-Line, Fluoroquinolones, Aminoglycosides, Cyclic Polypeptides, Novel and Repurposed Anti-Tuberculosis Drugs". Journal of Biomedical Research & Environmental Sciences 3, n.º 8 (septiembre de 2022): 988–93. http://dx.doi.org/10.37871/jbres1542.
Texto completoShen, Xin, Guo-miao Shen, Jie Wu, Xiao-hong Gui, Xia Li, Jian Mei, Kathryn DeRiemer y Qian Gao. "Association between embB Codon 306 Mutations and Drug Resistance in Mycobacterium tuberculosis". Antimicrobial Agents and Chemotherapy 51, n.º 7 (16 de abril de 2007): 2618–20. http://dx.doi.org/10.1128/aac.01516-06.
Texto completoPecho-Silva, Samuel, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, Jorge L. Maguina, Ali A. Rabaan, Luis Rene Quiroz-Ramirez, Kovy Arteaga-Livias y Alfonso J. Rodriguez-Morales. "The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis". Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 15, n.º 4 (8 de febrero de 2023): 622–25. http://dx.doi.org/10.35434/rcmhnaaa.2022.154.1501.
Texto completoYadav, Snehlata y Balasubramanian Narasimhan. "New Insights in Design and Development of Antitubercular Drugs". Current Bioactive Compounds 16, n.º 1 (20 de febrero de 2020): 13–23. http://dx.doi.org/10.2174/1573407215666190409153756.
Texto completoShaji, Jessy y Mahmood Shaikh. "DRUG-RESISTANT TUBERCULOSIS: RECENT APPROACH IN POLYMER BASED NANOMEDICINE". International Journal of Pharmacy and Pharmaceutical Sciences 8, n.º 10 (12 de agosto de 2016): 1. http://dx.doi.org/10.22159/ijpps.2016v8i10.11295.
Texto completoVelayati, A. A., P. Farnia, M. A. Merza, G. K. Zhavnerko, P. Tabarsi, L. P. Titov, J. Ghanavei et al. "New insight into extremely drug-resistant tuberculosis: using atomic force microscopy". European Respiratory Journal 36, n.º 6 (30 de noviembre de 2010): 1490–93. http://dx.doi.org/10.1183/09031936.00064510.
Texto completoSaroha, Deepika, Divyani Garg, Ashok Kumar Singh y Rajinder K. Dhamija. "Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum". Indian Journal of Tuberculosis 67, n.º 3 (julio de 2020): 389–92. http://dx.doi.org/10.1016/j.ijtb.2019.11.012.
Texto completoSarkar, Susmita y Mavanur R. Suresh. "An Overview Of Tuberculosis Chemotherapy – A Literature Review". Journal of Pharmacy & Pharmaceutical Sciences 14, n.º 2 (27 de abril de 2011): 148. http://dx.doi.org/10.18433/j33591.
Texto completoMaslow, Elizabeth R., Richard L. Lubman y Peter F. Barnes. "Tuberculosis: An Update for Clinicians". Journal of Intensive Care Medicine 11, n.º 5 (septiembre de 1996): 233–45. http://dx.doi.org/10.1177/088506669601100501.
Texto completoBaveja, C. P., Gumma Vidyanidhi, Manisha Jain, Trishla Kumari y V. K. Sharma. "Drug-resistant genital tuberculosis of the penis in a human immunodeficiency virus non-reactive individual". Journal of Medical Microbiology 56, n.º 5 (1 de mayo de 2007): 694–95. http://dx.doi.org/10.1099/jmm.0.46960-0.
Texto completoOudghiri, Amal, Ghizlane Momen, Achraf Aainouss, Amin Laglaoui, My Driss El Messaoudi, Mohammed El Mzibri y Imane Chaoui. "Genotypic diversity of multi- and pre-extremely drug-resistant Mycobacterium tuberculosis isolates from Morocco". PLOS ONE 16, n.º 7 (2 de julio de 2021): e0253826. http://dx.doi.org/10.1371/journal.pone.0253826.
Texto completoPhua, Chee Kiang, Cynthia BE Chee, Angeline PG Chua, Suay Hong Gan, Aneez DB Ahmed y Yee Tang Wang. "Managing a Case of Extensively Drug-Resistant (XDR) Pulmonary Tuberculosis in Singapore". Annals of the Academy of Medicine, Singapore 40, n.º 3 (15 de marzo de 2011): 132–35. http://dx.doi.org/10.47102/annals-acadmedsg.v40n3p132.
Texto completoTeneva, Yoanna, Rumyana Simeonova, Violeta Valcheva y Violina T. Angelova. "Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide–Hydrazone and Thiadiazole Derivatives Targeting InhA". Pharmaceuticals 16, n.º 4 (23 de marzo de 2023): 484. http://dx.doi.org/10.3390/ph16040484.
Texto completoArthur, Patrick K., Vincent Amarh, Precious Cramer, Gloria B. Arkaifie, Ethel J. S. Blessie, Mohammed-Sherrif Fuseini, Isaac Carilo, Rebecca Yeboah, Leonard Asare y Brian D. Robertson. "Characterization of Two New Multidrug-Resistant Strains of Mycobacterium smegmatis: Tools for Routine In Vitro Screening of Novel Anti-Mycobacterial Agents". Antibiotics 8, n.º 1 (2 de enero de 2019): 4. http://dx.doi.org/10.3390/antibiotics8010004.
Texto completoGul, Sana, Ruqaiya Khalil, Zaheer Ul-Haq y Mohammad S. Mubarak. "Computational Overview of Mycobacterial Thymidine Monophosphate Kinase". Current Pharmaceutical Design 26, n.º 15 (18 de mayo de 2020): 1676–81. http://dx.doi.org/10.2174/1381612826666200403114152.
Texto completoMakarova, M. V. y L. D. Guntupova. "No ntuberculous Mycobacteria". BIOpreparations. Prevention, Diagnosis, Treatment 20, n.º 2 (26 de junio de 2020): 97–102. http://dx.doi.org/10.30895/2221-996x-2020-20-2-97-102.
Texto completoDanilenko, V. N. "Development of a technological platfom for creating innovative anti-tb drugs effective against multi-drug-resistant strains". Вестник Российской академии наук 89, n.º 5 (6 de mayo de 2019): 427–35. http://dx.doi.org/10.31857/s0869-5873895427-435.
Texto completoCui, Ze-Jia, Wei-Tong Zhang, Qiang Zhu, Qing-Ye Zhang y Hong-Yu Zhang. "Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of Mycobacterium tuberculosis". Protein & Peptide Letters 27, n.º 8 (24 de septiembre de 2020): 711–17. http://dx.doi.org/10.2174/0929866527666200313113157.
Texto completoDuc, Nguyen Minh, Hanki Lee, Joo Won Suh, Vo Thi Bich Thuy, Nghiem Ngoc Minh y Nguyen Phan Lan Hong. "The high-throughput screening system for inhibitor Mycobacterium tuberculosis compounds based on ATP hydrolysis activity of recombinant protein ClpC1". Vietnam Journal of Biotechnology 18, n.º 2 (3 de noviembre de 2020): 239–47. http://dx.doi.org/10.15625/1811-4989/18/2/14908.
Texto completoLavrova, Anastasia I. y Eugene B. Postnikov. "An Improved Diagnostic of the Mycobacterium tuberculosis Drug Resistance Status by Applying a Decision Tree to Probabilities Assigned by the CatBoost Multiclassifier of Matrix Metalloproteinases Biomarkers". Diagnostics 12, n.º 11 (17 de noviembre de 2022): 2847. http://dx.doi.org/10.3390/diagnostics12112847.
Texto completoMunro, A. W., K. J. McLean, K. R. Marshall, A. J. Warman, G. Lewis, O. Roitel, M. J. Sutcliffe et al. "Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis". Biochemical Society Transactions 31, n.º 3 (1 de junio de 2003): 625–30. http://dx.doi.org/10.1042/bst0310625.
Texto completoKryzhanovsky, D. G., N. A. Marchenko y V. A. Freivald. "Definition of drug resistance of Mycobacterium tuberculosis to antituberculosis drugs in patients with multidrugresistant tuberculosis and TB with extremely drug resistant depending on the case of the disease." Medicni perspektivi (Medical perspectives) 19, n.º 4 (24 de noviembre de 2014): 84–89. http://dx.doi.org/10.26641/2307-0404.2014.4.35801.
Texto completoLu, Yu, Meiqin Zheng, Bin Wang, Lei Fu, Weijie Zhao, Peng Li, Jian Xu et al. "Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation". Antimicrobial Agents and Chemotherapy 55, n.º 11 (15 de agosto de 2011): 5185–93. http://dx.doi.org/10.1128/aac.00699-11.
Texto completoGrenkova, T. A., A. I. Chizhov, M. P. Gusarova y N. V. Gudova. "Study of the Effectiveness against Test Strain Mycobacterium terrae DSM 43227 of Some Substances Containing Fragment of Phenolic". Epidemiology and Vaccine Prevention 15, n.º 4 (20 de agosto de 2016): 37–41. http://dx.doi.org/10.31631/2073-3046-2016-15-4-37-41.
Texto completoOliveira, Gabriel S., Raquel P. Costa, Paula Gomes, Maria Salomé Gomes, Tânia Silva y Cátia Teixeira. "Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review". Pharmaceuticals 14, n.º 4 (2 de abril de 2021): 323. http://dx.doi.org/10.3390/ph14040323.
Texto completoSilva, Aleidy, Bai-Yu Lee, Daniel L. Clemens, Theodore Kee, Xianting Ding, Chih-Ming Ho y Marcus A. Horwitz. "Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model". Proceedings of the National Academy of Sciences 113, n.º 15 (28 de marzo de 2016): E2172—E2179. http://dx.doi.org/10.1073/pnas.1600812113.
Texto completoMartin, Carlos, Nacho Aguilo, Dessislava Marinova y Jesus Gonzalo-Asensio. "Update on TB Vaccine Pipeline". Applied Sciences 10, n.º 7 (10 de abril de 2020): 2632. http://dx.doi.org/10.3390/app10072632.
Texto completoZitko, Jan y Martin Doležal. "Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis". Current Medicinal Chemistry 25, n.º 38 (7 de enero de 2019): 5142–67. http://dx.doi.org/10.2174/0929867324666170920154325.
Texto completoUgwu, D. I., B. E. Ezema, F. U. Eze y D. I. Ugwuja. "Synthesis and Structural Activity Relationship Study of Antitubercular Carboxamides". International Journal of Medicinal Chemistry 2014 (30 de diciembre de 2014): 1–18. http://dx.doi.org/10.1155/2014/614808.
Texto completoNanovic, Zorica, Biserka Kaeva Jovkovska, Gorica Breskovska y Milena Petrovska. "Key Issues in the Management of Multi-Drug Resistant Tuberculosis: A Case Report". Open Access Macedonian Journal of Medical Sciences 6, n.º 7 (14 de julio de 2018): 1282–88. http://dx.doi.org/10.3889/oamjms.2018.290.
Texto completoGupta, Shradheya R. R., Ekta Gupta, Avnam Ohri, Sandeep Kumar Shrivastava, Sumita Kachhwaha, Vinay Sharma, Rupesh Kumar Mishra y Ravi Ranjan Kumar Niraj. "Comparative Proteome Analysis of Mycobacterium Tuberculosis Strains - H37Ra, H37Rv, CCDC5180, and CAS/NITR204: A Step Forward to Identify Novel Drug Targets". Letters in Drug Design & Discovery 17, n.º 11 (23 de octubre de 2020): 1422–31. http://dx.doi.org/10.2174/1570180817999200531165148.
Texto completoElger, B. S., F. Mirzayev, S. Afandiyev y E. Gurbanova. "Ethical issues in tuberculosis screening and the use of new drugs for prisoners". International Journal of Tuberculosis and Lung Disease 24, n.º 5 (1 de mayo de 2020): 57–60. http://dx.doi.org/10.5588/ijtld.17.0899.
Texto completoБудрицкий, А. М., В. А. Серёгина y Н. С. Правада. "Structure and Dynamics of Drug Resistance in Patients with Respiratory Tuberculosis". Клиническая инфектология и паразитология, n.º 1 (12 de abril de 2021): 17–28. http://dx.doi.org/10.34883/pi.2021.10.1.022.
Texto completoEsposito, Susanna. "TUBERCULOSIS IN CHILDREN". Mediterranean Journal of Hematology and Infectious Diseases 5, n.º 1 (4 de noviembre de 2013): e2013064. http://dx.doi.org/10.4084/mjhid.2013.064.
Texto completoMoni, Esther Del florence Ndedi, Patrick Hervé Diboue Betote, Christelle Wayoue Kom, Chimène Félicite Mekoulou Benga, Armelle Deutou Tchamgoue y Maximilienne Ascension Nyegue. "Inhibitory effects of hydroethanolic extracts from three Cameroonian medicinal plants on proteins inflammation and growth of multi-resistant strains of Mycobacterium tuberculosis". Journal of Drug Delivery and Therapeutics 11, n.º 4-S (15 de agosto de 2021): 15–21. http://dx.doi.org/10.22270/jddt.v11i4-s.4930.
Texto completoArbex, Marcos Abdo, Hélio Ribeiro de Siqueira, Lia D'Ambrosio y Giovanni Battista Migliori. "The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases". Jornal Brasileiro de Pneumologia 41, n.º 6 (diciembre de 2015): 554–59. http://dx.doi.org/10.1590/s1806-37562015000000299.
Texto completoLi, Lei, Eungyu Lee y Neil Shaw. "Expression, purification and crystallization of phosphoribosyl transferase from a mycobacteriophage". Acta Crystallographica Section F Structural Biology Communications 74, n.º 3 (26 de febrero de 2018): 161–65. http://dx.doi.org/10.1107/s2053230x18002480.
Texto completoDaneshfar, Sara, Azar Dokht Khosravi y Mohammad Hashemzadeh. "Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran". PLOS ONE 17, n.º 8 (12 de agosto de 2022): e0267320. http://dx.doi.org/10.1371/journal.pone.0267320.
Texto completoBespyatykh, Julia, Egor Shitikov, Dmitry Bespiatykh, Andrei Guliaev, Ksenia Klimina, Vladimir Veselovsky, Georgij Arapidi et al. "Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy". Pathogens 9, n.º 2 (18 de febrero de 2020): 131. http://dx.doi.org/10.3390/pathogens9020131.
Texto completoDas, Rina, Gyati S. Asthana, Krishan A. Suri, Dinesh Mehta y Abhay Asthana. "Recent Developments in Azole Compounds as Antitubercular Agent". Mini-Reviews in Organic Chemistry 16, n.º 3 (25 de enero de 2019): 290–306. http://dx.doi.org/10.2174/1570193x15666180622144414.
Texto completoPavlenko, E. P., N. V. Rachina y S. V. Epifanova. "The surfactant inhaled therapy in a complex lung tuberculosis treatment: clinical reviews". Meditsinskiy sovet = Medical Council, n.º 23 (18 de enero de 2023): 118–24. http://dx.doi.org/10.21518/2079-701x-2022-16-23-118-124.
Texto completoFoo, Caroline Shi-Yan, Benoit Lechartier, Gaëlle S. Kolly, Stefanie Boy-Röttger, João Neres, Jan Rybniker, Andréanne Lupien, Claudia Sala, Jérémie Piton y Stewart T. Cole. "Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis". Antimicrobial Agents and Chemotherapy 60, n.º 11 (15 de agosto de 2016): 6451–59. http://dx.doi.org/10.1128/aac.01523-16.
Texto completoVyazovaya, Anna, Igor Mokrousov, Natalia Solovieva, Alexander Mushkin, Olga Manicheva, Boris Vishnevsky, Viacheslav Zhuravlev y Olga Narvskaya. "Tuberculous Spondylitis in Russia and Prominent Role of Multidrug-Resistant Clone Mycobacterium tuberculosis Beijing B0/W148". Antimicrobial Agents and Chemotherapy 59, n.º 4 (2 de febrero de 2015): 2349–57. http://dx.doi.org/10.1128/aac.04221-14.
Texto completoProwse, Stephen J. y John S. MacKenzie. "Emerging Infectious Disease". Microbiology Australia 30, n.º 4 (2009): 112. http://dx.doi.org/10.1071/ma09112.
Texto completoAme, Mohammedkemal Mustefa. "Review on the Global Public Health Issue of Antibiotic Resistance and Potential Solutions". Public Health Open Access 7, n.º 1 (2023): 1–11. http://dx.doi.org/10.23880/phoa-16000233.
Texto completoNdjeka, N., J. Hughes, A. Reuter, F. Conradie, M. Enwerem, H. Ferreira, N. Ismail et al. "Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?" International Journal of Tuberculosis and Lung Disease 24, n.º 10 (1 de octubre de 2020): 1073–80. http://dx.doi.org/10.5588/ijtld.20.0174.
Texto completo